Piero Maria Stefani

7PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesHaematological tumoursMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Mar 09, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study.

Nicolò Danesin, Francesco Autore, Anna Maria Frustaci

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|May 16, 2024
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.

Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius

|Jul 05, 2022
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.

Chiara Rusconi, Chan Y Cheah, Toby A Eyre

|Jun 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.

Simone Ferrero, Daniele Grimaldi, Elisa Genuardi

Pageof 2

Frequent Collaborators

4 joint publications

Carlo Visco

3 joint publications

Stefan Hohaus

3 joint publications

Francesca Maria Quaglia

3 joint publications

Francesco Piazza